Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
46 participants
OBSERVATIONAL
2021-11-01
2022-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Sample size A sample of 23 from the positive group and 23 from the negative group achieve 80% power to detect a difference of 0,2300 between the area under the receiver operating characteristic (ROC) curve (AUC) under the null hypothesis of ,5000 and an AUC under the alternative hypothesis of 0,7300 using a two-sided z-test at a significance level of 0,05000. The data are continuous responses. The AUC is computed between false positive rates of 0,000 and 1,000. The ratio of the standard deviation of the responses in the negative group to the standard deviation of the responses in the positive group is 1,000.
Statistical analysis:
All statistical analysis was performed using IBM SPSS for Windows Version 23.0 software. Descriptive statistics for continuous variables were shown as mean ± standard deviation (SD) or median \[inter-quartile range (IQR); 25-75th percentile\]. Categorical variables were shown as the number of patients and percentage (%). Whether the distributions of continuous variables were normal or not was determined by the Shapiro Wilks test. Correlations between continuous variables were given by Spearman Correlation Coefficient. Discriminative ability of the CSA was determined by ROC curve analysis. Optimal cut-off value was given by Youden index. Sensitivity, specificity, positive and negative predictive value were calculated at this point. A p value less than 0.05 was considered statistically significant.
Stepwise linear regression analysis was applied to estimate CSA. The variables those p values \<0.20 in the univariate analysis were included in multiple regression model. The independent variables were determined as age, BMI and CSA-RLD. The adequacy of the established regression models was demonstrated by R2.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1 (Patients who recorded as Grade 0)
Patients whose antrum appears empty in supine and right lateral decubitus (RLD) positions by gastric ultrasound (Grade 0). Groups are classified according to the qualitative evaluation of the antrum by gastric sonographic examination.
The nature of the gastric contents (empty, clear liquid, dark liquid/solid) is established based on the qualitative findings by gastric antral ultrasonography. The qualitative evaluation of the antrum was recorded according to the 3-point grading system as Grade 0, Grade 1, and Grade 2.
Grade 0: antrum appears empty in both positions. Grade 1: antrum appears empty in the supine position but a small volume of gastric clear fluid is visible in the RLD position.
Grade 2: antral clear fluid visualized in both the supine and RLD position
Group 1 (Patients who recorded as Grade 0)
When the gastric contents were evaluated with the upper gastrointestinal endoscopy, the stomach was completely empty in Group 1 that patients who recorded as Grade 0.
Group 2 ( Patients who recorded as Grade 1)
Patients whose antrum appears empty in the supine position but a small volume of gastric clear fluid is visible in the RLD position by gastric ultrasound (Grade 1). Groups are classified according to the qualitative evaluation of the antrum by gastric sonographic examination The nature of the gastric contents (empty, clear liquid, dark liquid/solid) is established based on the qualitative findings by gastric antral ultrasonography. The qualitative evaluation of the antrum was recorded according to the 3-point grading system as Grade 0, Grade 1, and Grade 2.
Grade 0: antrum appears empty in both positions. Grade 1: antrum appears empty in the supine position but a small volume of gastric clear fluid is visible in the RLD position.
Grade 2: antral clear fluid visualized in both the supine and RLD position
Group 2 ( Patients who recorded as Grade 1)
When the gastric contents were evaluated with the endoscope, small volume of gastric clear fluid was visible and gastric content aspirated and measured in Group 2 that patients who recorded as Grade 1.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Group 1 (Patients who recorded as Grade 0)
When the gastric contents were evaluated with the upper gastrointestinal endoscopy, the stomach was completely empty in Group 1 that patients who recorded as Grade 0.
Group 2 ( Patients who recorded as Grade 1)
When the gastric contents were evaluated with the endoscope, small volume of gastric clear fluid was visible and gastric content aspirated and measured in Group 2 that patients who recorded as Grade 1.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Previous lower esophageal or gastric surgery
* Non-adherence with the fasting regimen
* More than 5 minutes between gastric sonography and endoscopy
24 Months
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Feyza Sever
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Feyza Sever
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Feyza Sever
Ankara, Çankaya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E2-21-490
Identifier Type: -
Identifier Source: org_study_id